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Populärvetenskaplig 
sammanfattning 
Avbildning genom detektion av Cherenkovstrålning är en nuklearmedicinsk 
bildtagningsmetod där man utnyttjar det synliga ljus som kallas Cherenkovstrålning. 
Detta ljus sänds ut när hastigheten hos en laddad partikel överstiger hastigheten av 
ljuset i ett visst medium och kan användas för att lokalisera fördelningen av en 
radionuklid i en kropp. 
Syftet med denna studie är att undersöka möjligheten att kvantitativt analysera 
avbildning med Cherenkovstrålning för att avgöra huruvida metoden kan användas 
som ett dosimetriskt verktyg vid systemisk strålterapi. 
Systemisk strålterapi är en metod för behandling av cancer där radioaktiva isotoper 
administreras till patienterna för att uppnå celldöd hos tumörcellerna. För att uppnå 
ett bättre resultat kan radioisotoperna märkas med en monoklonal antikropp som 
binder till receptorer hos cancercellerna.  Vissa typer av cancerceller har visat sig 
överuttrycka vissa receptorer vilket gör det möjligt att rikta behandlingen mer direkt 
mot tumören.  
För att säkerställa terapeutisk effekt måste man försäkra sig om att radioisotopen 
ackumuleras i tumören under en tillräckligt lång tid. Det är också viktigt att 
behandlingen är selektiv så att friska organ kan besparas onödig stråldos. 
Effektiviteten och specificiteten hos ett isotop-antikropp komplex undersöks 
rutinmässigt med prekliniska dosimetristudier. 
Molekylär bildtagning med nuklearmedicinska bildtagningsmetoder som PET och 
SPECT möjliggör visualisering av cellfunktion och molekylära processer i levande 
organismer utan att störa dessa processer. De många modaliteterna inom fältet är 
applicerbara på bland annat diagnosticeringen av cancer, neurologiska sjukdomar 
och hjärt-kärlsjukdomar.  
Optiska bildtagningsmetoder, såsom fluorescens- och bioluminescensbildtagning, är 
till skillnad från nuklearmedicinska bildtagningsmetoder lätta att hantera och 
instrumenten är mycket billigare än de som krävs för PET och SPECT. Av dessa 
anledningar föredrar många att använda sig av optiska bildtagningsmetoder för att 
undersöka molekylära processer vid grundläggande och biomedicinska studier. 
Optiska bildtagningsmetoder har hög känslighet och utmärkt tidsupplösning, men 
kvantifiering baserad på den optiska signalen är osäker. Metoderna har dock 
begränsad klinisk tillämpning på grund av absorption och spridning av ljuset när det 
passerar genom kroppen, vilket leder till låg penetration av vävnad. 
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På senare tid har det funnits ett ökande intresse för optiska tekniker för avbildning av 
radioisotoper, tekniker baserade på emission av Cherenkovstrålning. Det är av stort 
intresse att ytterligare undersöka möjligheten att använda sig av bildtagning med 
Cherenkovljus som ytterligare ett verktyg för preklinisk dosimetri. 
 Jämfört med kliniskt använda molekylära bildtagningsmetoder som PET och SPECT är 
Cherenkov-bildtagning en enkel och kostnadseffektiv bildtagningsmetod, vilket gör 
metoden intressant för exempelvis screening.   
Avbildning med Cherenkovstrålning kan användas för att lokalisera radionuklider i 
prekliniska djurstudier, detta betyder att metoden skulle kunna användas för att 
studera selektivt upptag i ytliga tumörer.  
Slutligen skulle denna bildtagningsmetod kunna utgöra ett alternativ till preklinisk 
PET, med lägre kostnad och högre genomströmning. 
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Abstract 
Cherenkov emission imaging is a new optical imaging technique in nuclear medicine 
that takes advantage of the fact that most positron emitting radionuclides have a 
sufficient energy to produce Cherenkov photons.  The Cherenkov photons can then 
be detected with sensitive CCD camera systems.  
Due to the recent demonstration of detectable amounts of Cherenkov light escaping 
from nuclide bearing mice the interest in Cherenkov radiation has increased. The 
demonstrated results of animal studies give an implication that it is possible to use 
the CR phenomenon for medical research and possibly for clinical purposes.  
A large plethora of clinically used radiopharmaceuticals for imaging and therapy can 
be imaged with Cherenkov luminescence imaging (CLI). This means that it is possible 
to use the method to follow the distribution of these radiopharmaceuticals in vivo, 
thereby the method could possibly be used as a dosimetry tool in systemic radiation 
therapy (SRT).  
Several research groups have investigated the correlation between CLI and PET-
imaging, and an excellent correlation between the bio-distributions obtained with 
the two methods has been found. Compared to currently used imaging methods such 
as PET and SPECT, CLI is a simple method which makes it interesting for e.g. screening 
purposes. The equipment needed for CLI is less expensive than PET and SPECT 
equipment, meaning that it would be a good alternate method for smaller 
laboratories with a restricted budget. 
The aim of this study is to investigate the possibility for quantitative measurements 
and to quantitatively analyse the use of Cherenkov emission imaging in optical 
phantoms and pre-clinical animal models.  
This study includes several experiments where the relation between different optical 
properties of the studied media and the emitted Cherenkov radiation is investigated. 
The results shown by the work in this thesis are in good agreement with the 
theoretical expectations and results shown by other research groups. 
Cherenkov emission imaging can be used for radionuclide localization in preclinical 
animal studies, meaning that the method could be used to study selective uptake in 
superficial tumours. The CLI method could provide us with a low-cost high-
throughput alternative to preclinical PET.    
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1. Introduction 
 
1.1 Motivation of the thesis 
The aim of the work presented in this thesis is to quantitatively analyse the use of 
Cherenkov emission imaging in phantoms and pre-clinical animal models. The 
motivation of the work is to investigate the feasibility of Cherenkov emission imaging 
as a tool for dosimetry studies on systemic radiation therapy.  
Cherenkov emission imaging is of great interest since it is a simple method compared 
to positron emission tomography (PET) and single photon emission computed 
tomography (SPECT). It is possible to use Cherenkov emission imaging as a simple 
screening instrument instead of more complicated methods.  
Another interesting aspect is that the method allows for imaging of pure beta 
emitters, which is not possible with the pre-clinical methods used today.  
 
1.2 Systemic radiation therapy 
Systemic radiation therapy (SRT) is a cancer treatment modality in which radioactive 
isotopes are administered to patients in order to achieve tumour cell kill. To reach a 
better tumour cell kill the radioisotope can be labelled with a monoclonal antibody 
(mAb) that binds to specific receptors on the cancer cells. Some types of cancer cells 
have been shown to overexpress certain receptors, providing means for specific 
tumour targeting [1-3].  
To be able to achieve therapeutic efficacy, one need to assure that a sufficient 
activity of the radioisotope is accumulated in the tumour for a sufficient period of 
time. It is also of great importance that the selectivity is high enough to spare healthy 
organs. The efficiency and the specificity of an isotope-mAb compound are routinely 
investigated in pre-clinical dosimetry studies [1-3]. 
A lot of the work that is done to develop new radiopharmaceuticals is based on 
preclinical animal studies. In this type of studies the distribution of the radiolabeled 
pharmaceuticals in the animals is investigated over time.  
 
1.3 Molecular imaging in nuclear medicine 
Molecular imaging with nuclear imaging modalities such as PET and SPECT enables 
visualization of cellular function and molecular processes in living organisms without 
perturbing them. The multiple and numerous potentialities of this field are applicable 
to the diagnosis of diseases such as cancer, neurological and cardiovascular diseases. 
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Optical imaging, such as fluorescence and bioluminescence imaging, is in contrast to 
nuclear imaging easy to handle and the instrumentation is less expensive than that of 
PET and SPECT. This is one reason why many basic and biomedical studies prefer 
optical imaging to examine molecular processes in living systems. Optical imaging 
methods have high sensitivity and excellent temporal resolution.  However, 
quantification based on the optical signal is inaccurate and has limited applications in 
clinics due to the absorption and scattering of light in body and resulting low tissue 
penetration [4]. 
Recently there has been an escalating interest in optical techniques for radioisotope 
imaging [5] and electron beam imaging[6], techniques that rely on Cherenkov 
emission. Optical imaging, when compared to scintillation camera imaging, allows a 
higher throughput as more pre-clinical models can be imaged at the same time [7]. 
To investigate the potential of Cherenkov emission imaging as an additional tool for 
pre-clinical radioisotope dosimetry is of great interest. 
Despite the influence of absorption and scattering, recent studies have shown 
satisfactory correlations between Cherenkov emission and PET signals using 18F and 
89Zr. The limitations in sensitivity, caused by the diminished penetration depth due to 
scattering and absorption, limits the clinical use of Cherenkov emission imaging for 
whole body tomography. However, for preclinical studies Cherenkov emission 
imaging could provide a high-throughput precursor or validation method for in vivo 
PET studies [5].  
 
2. Cherenkov emission 
Cherenkov emission imaging is a simple imaging method compared to other 
molecular imaging methods that are currently used, such as PET and SPECT. This 
makes Cherenkov emission imaging an interesting method for e.g. screening 
purposes.  
 
2.1 Historical background 
Optical emission induced by relativistic particles was first described by Pavel 
Cherenkov in the early 1930s [6]. Cherenkov radiation (CR) is emission of visible light 
that occurs when a charged particle travels through a dielectric medium at a speed 
that exceeds the phase velocity of light in that medium. When these conditions are 
fulfilled a photonic shockwave is produced, this is comparable to the sonic 
shockwave associated with supersonic bodies in air [8].  
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In media such as biologic tissue and water the speed of light, vn, is less than c. The 
reduction of the speed of light in a medium is due to the interaction of light with the 
material and is proportional to the refractive index of the medium according to Eq. 
(1) [5, 9]. 
 
When the speed of a particle nears the speed of light, the relativistic kinetic energy, 
E, is calculated according to Eq. (2) [5, 9].  
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The required conditions for Cherenkov emission renders a threshold condition given 
by Eq. (3). 
 
In Eq. (3), n is the refractive index of the medium, β is related to the energy of the 
particle and defined by:  
 
Eq. (4) is valid for an electron or a positron with the energy E, since 511 keV is the 
rest energy of one of these particles.  
In water the threshold energy of electrons is 264 keV, while in tissue, assuming a 
refractive index of 1.4, the threshold energy is 219 keV. Several of the radioisotopes 
used in biomedical imaging satisfy the Cherenkov emission criterion given by Eq. (3) 
[6]. 
The Cherenkov photons are produced in a continuous spectrum from the near 
ultraviolet through the visible spectrum, with intensity inversely proportional to the 
square of the photon wavelength [5, 8, 10]. The data presented by Robertson et al. 
[5], see Figure 2.1, confirms that the produced light follows an inverse relationship 
with the square of the wavelength.  
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Figure 2. 1: Results from measurements made by Robertson et al. [5] showing 
that the intensity of the emitted Cherenkov radiation is inversely proportional to 
the wavelength. 
 
The number of produced photons depends on the initial energy of the charged 
particle. Ross et al. [10] has calculated the Cherenkov photon yield in seven spectral 
regions for electrons with different energies ranging from 275 to 4000 keV, a 
selection of the calculated photon yields are tabulated in Table 2.1. The tabulated 
photon yields show that the higher initial energy a particle has the more photons it 
will generate before dropping below the Cherenkov emission threshold.  
 
Table 2. 1:  Cherenkov photon yields of electrons in water for selected spectral ranges adopted from 
Ross et al. [10]. 
 
  
                                  Photons/spectral region [nm]    
Electron 
energy [keV] 
250-300 300-350 350-400 400-450 450-500 500-550 500-600 
275 0,0032 0,0023 0,0017 0,0013 0,0011 0,0009 0,0007 
300 0,0041     0,0029 0,0022 0,0017 0,0013 0,0011 0,0009 
400 0,723 0,513 0,385 0,300 0,240 0,196 0,163 
500 2,22 1,58 1,18 0,992 0,737 0,604 0,501 
600 4,45 3,16 2,37 1,85 1,48 1,21 1,00 
800 10,7 7,59 5,69 4,43 3,54 2,90 2,41 
1000 18,9 13,4 10,0 7,82 6,25 5,12 4,25 
2000 78,8 56,0 42,0 32,7 26,1 21,4 17,8 
3000 160 114 85,1 66,3 53,0 43,4 36,0 
4000 215 181 136 106 84,5 69,3 57,5 
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Several of the medical radioisotopes currently in clinical use emit beta particles with 
kinetic energies that fall within the range of Cherenkov photon generation, seen in 
Table 2.1. [9]. Thus, there is a potential application of Cherenkov emission in medical 
radionuclide imaging.  
 
2.2 Cherenkov emission imaging of small animals 
The recent increased interest in Cherenkov radiation is due to the demonstration of 
detectable amounts of light escaping from a radionuclide bearing live mouse, which 
implies that there is a possibility to utilize the CR phenomenon for medical research 
and perhaps for clinical purposes [8]. Cherenkov radiation from common PET 
nuclides has been detected in vivo in live mice using sensitive Charge Coupled Device 
(CCD) optical imaging systems [11].  
Recently several groups, including Robertson et al. [5], Spinelli et al. [12] and Mitchell 
et al. [13] established an imaging approach called Cherenkov emission imaging (CLI) 
for in vivo imaging of small animals such as mice. Cherenkov emission imaging is 
based on detection of Cherenkov radiation generated by beta particles as they travel 
through tissue with an energy that satisfies the threshold condition for Cherenkov 
emission. In both the studies mentioned the possibility of detecting Cherenkov 
radiation escaping from mice injected with 18F-FDG was investigated using widely 
available optical imaging instruments.  
The bio-distribution of a large variety of radiopharmaceuticals for both therapy and 
imaging can be imaged using Cherenkov radiation eliminating the need for expensive 
dedicated SPECT or PET tomographs [12]. All currently used positron emitting 
radionuclides have a sufficient energy to produce Cherenkov radiation detectable 
with sensitive optical imaging equipment [5]. It has also been experimentally 
confirmed that Cherenkov radiation from beta emitters can be used as a quantitative 
and qualitative tool for assessment of radiotracer distribution in vivo [14]. 
The correlation between PET and Cherenkov emission imaging has been investigated 
by several groups that have performed longitudinal imaging studies. An excellent 
correlation between the bio-distributions obtained with CLI and commercial 
preclinical PET has been found. It has also been found that changes with respect to 
time, tumour model and radiopharmaceutical formulation are consistent in CLI and 
PET data [14-16].  
The most commonly cited biomedical application of CLI is as a high throughput, low 
cost alternative to PET imaging, a method referred to as Cherenkov luminescence 
imaging [8]. The clinical use of CLI for whole body tomography will be restricted by 
the sensitivity limitations caused by scattering and absorption. For preclinical studies 
on the other hand, CLI could provide a high-throughput precursor or validation for 
PET studies in vivo [5].   
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A number of other possible applications for CR are suggested, applications such as 
using it as an alternative to bremsstrahlung for imaging of pure beta emitters or as an 
intra-operative or endoscopic imaging of targeted structures in humans. Other 
suggested applications are as an excitation source for different fluorophores, a higher 
resolution autoradiography method and as a light source for photodynamic therapy 
[8].  
To sum it up it should, in principle, be possible to apply the CLI method to any 
radioisotope emitting charged particles with an energy that exceed the threshold 
energy for production of Cherenkov radiation in the media [11].   
The big advantage with the CLI method is the possibility for cost-effective screening 
with high throughput. CLI could largely improve the throughput of current preclinical 
imaging since this method allows for imaging of 5 animals at the time with an 
integration time of 5 minutes, while PET allows for imaging of 1 or 2 animals per 10 
minutes [7, 16].   
Another advantage could be that the Cherenkov radiation is produced during the 
initial decay process, which makes it more localized to the actual decay event than 
the annihilation event tracked by PET imaging [5].  
The CLI method is believed to progress rapidly because of the improvement in 
throughput in combination with sensitivity to therapeutic effect, decreased 
equipment cost and the many available nuclear probes. The lowered cost for imaging 
systems will allow the technique to spread to smaller laboratories with limited 
budget [12, 16, 17].  
 
3. Light propagation in tissue 
Light, which is propagating in biological tissue, will interact with the constituents of 
the tissue. The two primary ways of interaction are elastic scattering and absorption. 
3.1 Absorption 
Light can be absorbed if encountering an absorbing chromophore with a difference in 
energy between electronic states that matches the energy carried by the optical 
radiation. This spectrally dependent absorption forms the basis for a wide selection 
of applications. The transmitted intensity, IT, decreases exponentially with the 
propagation distance, d, according to the Beer-Lambert law if the scattering of the 
light is negligible. The Beer-Lambert law is shown in Eq. (5). 
 
              
     (5) 
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The absorption coefficient, µa, in Eq. (5) is stating the probability of absorption per 
unit length. The absorption coefficient is essentially the summation of all 
chromophore contributions and it is given by: 
 
       ∑     [  ]
 
 (6) 
 
In Eq. (6) εi is the extinction coefficient for chromophore i and Ci is the 
concentration of this chromophore. The scattering in biological tissue is normally 
higher than the absorption, resulting in that the Beer-Lambert law only can be 
applied with modifications and on certain occasions [18]. The main absorbing 
chromophores in biological tissues are listed below. 
 
Haemoglobin  
There are two forms of haemoglobin; oxygenated and deoxygenated. The spectral 
absorption characteristics for the two forms of haemoglobin are different and this 
can be used to assess the oxygenation of the tissue [19, 20].  The oxygenation of the 
tissue is a valuable tool in assessment of hypoxia since the status of a tumour can 
show oxygen deficiency. 
 
Water 
Water is present in abundance in the entire body and it is normally represented by 
the water fraction. The water mainly absorbs the light in the near infrared 
wavelength region. 
 
Lipids 
This is the family name for a variety of several different substrate types.  One area 
where lipids play an important role is as building blocks in cell membranes. Like 
water, lipids absorb at longer wavelengths. Lipids are relatively weak absorbers 
compared to water [21].  
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Melanin 
Is present in superficial skin where it acts as a protecting layer against the sun’s ultra 
violet (UV) radiation; it is the melanin that is responsible for the colour of our skin. 
Melanin is not only found in the skin, it can also be found in for example the brain 
[22].  
 
Myoglobin 
There are two kinds of myoglobin; oxy- and deoxy-myoglobin, and the absorption 
characteristics are similar to the ones of haemoglobin. Myoglobin is primarily found 
in muscular tissues [23]. 
 
Cytochromes 
Cytochromes are different substrates that reflect the mitochondrial content. 
Spectroscopic assessment of these substrates could render information about the 
metabolism of the studied medium[24]. 
 
3.2 Scattering 
Cells with intracellular organelles and extracellular structures build up tissues. The 
structures of the cells form a complex matrix which macroscopically regulates the 
anatomy of the organs. The variety of cells throughout the body results in several 
different tissue types with different constituent composition. However, the origin of 
scattering is thought to be the same in the different tissue types. The scattering is 
due to the variation in refractive index within the medium [25]. 
Another property that affects the scattering is the size of the tissue components; the 
size distribution of tissue components range from nm-sized proteins to µm-sized 
cells. This fact has made it possible to use scattering-based diagnostic methods to 
probe morphological changes in the tissue [26, 27].  
 When the scattering properties are analysed theoretically one usually assume that 
the tissue components are spherically shaped particles. The Mie theory is then used 
to model the electromagnetic wave propagation. The scattering from one sphere can 
be described by the radiation caused by a dipole induced through the interaction 
with the incident electromagnetic field [28]. Scattering patterns from a limited 
number of spherical particles can very well be described by Mie theory, but the 
complexity of biological tissues makes it impractical to adopt in real applications.   
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In optical studies of tissue the macroscopic properties normally are of interest. Two 
physical quantities are defined; the scattering coefficient, µs, and the anisotropy 
factor, g. 
   〈      〉 (7) 
 
In Eq. (7) θ is the scattering angle and µs states the probability for scattering per unit 
length and g gives information about in what direction the light is scattered on 
average. Because of its composition, tissue has an anisotropy factor that is 
approaching unity, meaning that tissue is forward scattering. In highly scattering 
tissues the two quantities are combined into the reduced scattering coefficient, µs’, 
which is shown in Eq. (8) [29]. 
   
          (8) 
4. Cherenkov emission in optical phantoms 
Experiments with optical phantoms were made to investigate how the radiance of 
the Cherenkov emission is affected by different properties of the imaged object.  
 
4.1 Experimental setup 
The experimental setup consists of a charge coupled device (CCD) camera (Andor 
iKon-M DU934P-FI) mounted with the objective lens (Schneider Kreuznach Xenon 
25mm/0.95) inside a light tight enclosure. The CCD camera is also connected to a 
cooling system and a computer with the necessary imaging software to save and 
handle the images. A schematic view of the setup is shown in Figure 4.1. 
 
 
Figure 4. 1: A schematic image of the setup; to the left is the light tight enclosure in 
which the imaged objects were placed, to the right is the cooling system used to 
cool the camera and in the bottom of the figure is a laptop with imaging software. 
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During imaging the optical phantoms were placed in the light tight enclosure, the 
images were then acquired by the CCD which was cooled to between -65°C and           
-95°C. The phantoms were placed in the light tight enclosure to minimize the 
background light. To further suppress the background light the enclosure was 
covered with black fabric and the lights in the room were switched of during imaging. 
In order to better understand the setup a schematic image of the inside of the light 
tight enclosure is presented in Figure 4.2 and a photograph of a well plate inside the 
enclosure is shown in Figure 4.3. Well plates are placed on a plastic block to be at the 
right distance from the lens, in the experiments where a test tube is used as an 
optical phantom the tube is attached to a sample holder on the millimetre screw in 
the corner of the enclosure. The millimetre screw allows for the sample to be raised 
or lowered from the outside without the need to open the enclosure.   
 
 
Figure 4. 2: A schematic image of the inside of the light tight enclosure 
with a well plate phantom placed on a plastic block. The plastic block is 
covered with black paper to ensure that all light in the images originates 
from the phantom and not from the plastic it is placed on. 
 
 
Figure 4. 3: A photograph of the light tight enclosure containing a well plate 
phantom. To the right one can see the millimeter screw used to change the 
distance between the test tube phantoms and the lens. 
 
19 
 
One type of optical phantom consists of well plates with different mixtures of, water, 
bovine blood and Intralipid-20%® in order to mimic the optical properties of different 
tissues. Intralipid-20%® is an emulsion of soy bean oil (20%), egg phospholipids, 
glycerine and water, that in our experiments is used as a scattering medium [30]. In 
figure 4.4 a photograph of the well plate with the different mixtures is seen, in 
addition all the different mixtures are displayed in Table 4.1.  
 
 
Figure 4. 4: A photo of the type of well plate used, with the different mixtures 
of water, blood and Intralipid in the different wells. 
 
Table 4. 1: The different content of water, blood and Intralipid in the wells of the well plate. 
Mixtures  
Water volume 
[µl] 
Blood volume 
[µl] 
Intralipid-20% 
volume [µl] 
1200 0 0 
1200 5 0 
1200 10 0 
1200 20 0 
1200 30 0 
1200 0 40 
1200 5 40 
1200 10 40 
1200 20 40 
1200 30 40 
1200 0 100 
1200 5 100 
1200 10 100 
1200 20 100 
1200 30 100 
1200 0 175 
1200 5 175 
1200 10 175 
1200 20 175 
1200 30 175 
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The well plates with different mixtures of blood and Intralipid was used in the 
experiments where the effects of different optical properties were studied. In the 
experiments where the wavelength dependence was investigated the same mixture 
was used in all the wells.  
The other type of optical phantom consists of a test tube containing a liquid solution 
with the radionuclide, and a larger container with different mixtures of water, bovine 
blood and Intralipid in which the test tube is lowered.  A schematic of this setup is 
seen in Figure 4. 5. 
 
 
Figure 4. 5: A schematic image of the light tight enclosure containing 
the test tube mounted in the holder on the millimetre screw and 
lowered in a container with water, blood and Intralipid. 
 
The setup shown in Figure 4.5 was used for the experiments investigating how the 
radiance is affected by the choice of radionuclide and the energy of the chosen 
nuclide. The effect of the depth of the test tube in the larger phantom is also studied. 
 
4.2 Optical radiance as a function of activity 
To investigate how the radiance is affected by the activity we prepared a well plate 
phantom and let it decay while placed in the light tight enclosure. The radionuclide 
used was 18F, which has a half-life of approximately two hours, images were gathered 
every hour and the phantom was studied for about three half-lives.  
The results of these measurements are shown in Figure 4.6; the figure shows the 
relationship between radiance and activity for the well containing only water. 
However our measurements showed a linear relation with different inclination for all 
the different mixtures of water, Intralipid and bovine blood.  Our results are in 
agreement with the results shown by several other research groups, including 
Robertson et al. [5], Beattie et al.[8] and Xu et al.[9]. 
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Figure 4. 6: Radiance as a function of activity for the ROI of the well plate containing only 
water. 
 
In Figures 4.7 - 4.10 the mean radiance is plotted as a function of activity for all the 
different mixtures in the different wells and the relationship between radiance and 
activity was studied. The measurements show that all mixtures have a linear 
relationship between these properties, with different inclination for different 
concentrations of blood and Intralipid. 
 
 
Figure 4. 7: The radiance as a function of activity for the five different blood 
concentrations and 0 % Intralipid. 
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Figure 4. 8: The radiance as a function of activity for the five different blood 
concentrations for 2,5 % Intralipid. 
 
The graphs in Figures 4.7 and 4.8 show that when the bovine blood is added the 
signal is significantly reduced. This is obviously what is expected when an absorbing 
agent is added to the mixture. 
 
 
Figure 4. 9: The radiance as a function of activity for the four different concentrations of 
Intralipid without any blood in the mixtures. 
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Figure 4. 10: The radiance as a function of activity for the four different percentages 
of Intralipid and with 2.3 % blood in the mixture. 
 
As can be seen in Figures 4.9 and 4.10 there is an increase in radiance when a small 
amount of scattering material is added, however when more Intralipid is added the 
radiance decreases slightly with the amount of added scattering material.  
 
4.3 Influence of absorption on quantification 
The radiance per MBq was calculated and plotted against the concentration of 
bovine blood; this plot can be seen in Figure 4.11. The results of our measurements 
show that the radiance of the Cherenkov light decreases exponentially with 
increasing blood concentration. According to the Beer-Lambert law, see Eq. (5), this is 
expected for a non-scattering solution.  
 
 
Figure 4. 11: Radiance per MBq as a function of the blood concentration for the 
four different percentages of Intralipid. 
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4.4 Influence of scattering on quantification 
The radiance per MBq was plotted as a function of the percentage of Intralipid in the 
mixture for different levels of blood concentration, see Figure 4.12. The graph shows 
that a small amount of Intralipid gives rise to a higher signal, but for larger 
concentrations the Intralipid lowers the signal.   
The scattering will increase when Intralipid is added to the solution and as a result 
the propagation length of the optical photons will be longer. Photons that should 
have been lost through the sides and the bottom of the well will with an increased 
scattering have a higher probability of scattering in the direction towards the camera. 
When the concentration of Intralipid is increased further the scattering will result in a 
higher attenuation, which in turn will give a decreased inclination. 
 
 
Figure 4. 12: Radiance per MBq as a function of the concentration of Intralipid for the 
five different blood levels. 
 
4.5 Optical radiance as a function of the wavelength of light 
To investigate the wavelength dependence of the radiance images were gathered 
with different filters inserted between the well plate and the CCD. This was done for 
a well plate containing only water and a well plate with the same mixture of water, 
blood and Intralipid in all the wells. As can be seen in Figure 4.13 the expected 1/λ2 
dependency was achieved for the measurements with water in the wells and for the 
measurements with a mixture of water, bovine blood and Intralipid.   
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Figure 4. 13: The wavelength dependency of radiance for 
18
F in water (blue) and in a mixture 
of 1200 µl water, 10 µl of bovine blood and 100 µl Intralipid (red). 
 
4.6 Energy dependence of radiance 
An optical phantom consisting of a test tube at different depths in a larger container 
with different amounts of absorbing and scattering material was used for these 
experiments; the experimental setup was presented in Figure 4.5. Two different 
radionuclides were used, 18F and 89Zr, with maximal positron energies of 634 keV and 
905 keV respectively.  The beta spectra for the used nuclides are presented in Figure 
4.14 [31].  
 
 
Figure 4. 14: The beta spectra for 
18
F and 
89
Zr, data from RADAR [31]. 
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In Figures 4.15 and 4.17 Cherenkov emission images of the test tube containing the 
different nuclides at different depths in the phantom are shown and in Figures 4.16 
and 4.18 a line profile of the test tubes are presented. Some useful data for a 
comparison of the nuclides are presented in Table 4.2.  
 
 
Figure 4. 15: Cherenkov emission images of a test tube containing 
18
F, at a) 0 mm depth, 
b) 2.5 mm depth and c) 5mm depth in a liquid phantom. The red dotted line shows the 
placement of the line profile of the test tube; the profile is seen in Figure 4.16. 
 
 
Figure 4. 16: The line profile of the test tube from Figure 4.15 containing 
18
F. 
 
 
Figure 4. 17: Cherenkov emission images of a test tube containing 
89
Zr, at a) 0 mm depth, 
b) 2.5 mm depth and c) 5mm depth in a liquid phantom. The red dotted line shows the 
placement of the line profile of the test tube; the profile is seen in Figure 4.18. 
 
 
Figure 4. 18: The line profile of the test tube from Figure 4.17 containing 
89
Zr. 
 
d=0 mm
[Hb]=0%
d=2.5 mm
[Hb]=0%
d=5 mm
[Hb]=0%
0 100 200
0
2
4
6
Pixel
A
D
U
/M
B
q
19 MBq
0 100 200
0
2
4
6
Pixel
A
D
U
/M
B
q
18 MBq
0 100 200
0
2
4
6
Pixel
A
D
U
/M
B
q
16 MBq
d=0 mm
[Hb]=0%
d=2.5 mm
[Hb]=0%
d=5 mm
[Hb]=0%
0 100 200
0
5
10
15
Pixel
A
D
U
/M
B
q
11 MBq
0 100 200
0
5
10
15
Pixel
A
D
U
/M
B
q
11 MBq
0 100 200
0
5
10
15
Pixel
A
D
U
/M
B
q
11 MBq
a) b) c) 
a) b) c) 
a) b) c) 
a) b) c) 
27 
 
By using the Cherenkov photon yields calculated by Ross et al. [10] one can obtain 
the maximal number of photons created by a positron with certain energies. By 
summarizing the photon yields for all different spectral ranges one will get the total 
photon yield for the nuclides. The calculation gives us that a positron with the initial 
energy 634 keV will produce 18,72 photons before dropping below the threshold 
level and a positron with an initial energy of 905 keV will produce 51,48 photons. 
Since we measure radiance in number of photons per square centimetre per 
steradian per second, a higher radiance will be detected for the nuclide with the 
higher energy, simply because it produces a larger number of photons. 
 
Table 4. 2: Data for the different nuclides. 
Nuclide 
comparison 
  
Nuclide 18F 89Zr 
Mean energy [keV] 250  397 
Max. energy [keV] 634 905 
Max. ADU 3,9 10,84 
Cherenkov photon yield 18,72 51,48 
 
5. Cherenkov emission in vivo 
 
5.1 Study design 
In the in vivo experiments nude mice with HER2-expressing SKOV-3 xenografts were 
studied. The nude mice were injected with 89Zr-Df-Trastuzumab and PET-images of 
the mice were taken 2 days post injection. Tree days post injection Cherenkov 
emission images of the mice were retrieved, before the mice were dissected and 
images of the organs were acquired. The activities in the organs were then measured 
with a gamma counter, and a comparison was made between the PET and Cherenkov 
images. There also was a comparison made between the activity measurements and 
the response in the Cherenkov emission images.  
The exposure time for the Cherenkov emission images was 600 s. 
To calibrate the system a test tube containing 0.84 MBq of 89Zr was used, the 
Cherenkov emission image of this test tube is shown in Figure 5.1. The hot spot in the 
lower left corner is probably due to activity trapped in the silicone used to seal the 
tube and the reason for the lack of signal between the hot spot and the rest of the 
test tube is a piece of black tape on the test tube. 
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Figure 5. 1: A Cherenkov emission image of the test tube used 
for calibration of the system. 
 
5.2 Whole body small animal Cherenkov emission imaging 
The mice were placed in a light tight enclosure for Cherenkov emission imaging; 
images of the mice were then gathered for 600 s. with a CCD. A photograph and the 
Cherenkov emission image of the mice are shown in Figure 5.2 a) and Figure 5.2 b). 
As can be seen in the Cherenkov emission image most of the activity administered to 
mouse no 6 has ended up in the tail of the mouse, which is an indication of 
extravasation.  
 
      
Figure 5. 2: a) (left): Mouse 4, 5, 6 and 1 before placed in the dark box for imaging.  
b) (right): The Cherenkov emission image of the mice, the colour bar 
indicates the radiance [γ/cm
2
/sr/s]. 
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In the Cherenkov emission images one region of interest was drawn over the tumour 
area and another at the skin surface on each mouse. The mean radiance of all these 
regions of interest and the tumour to skin ratio of the radiance is presented in Table 
5.1. 
  
 
Table 5. 1: Mean radiance for tumour and skin regions of interest, and the ratio between tumour 
and skin radiances. 
Whole body   
Mouse ROI Mean 
radiance 
[γ/cm²/sr/s] 
 
      
    
 
1 Tumour 2239,5 1,6102 
 Skin 1390,8  
2 Tumour 3192,5 2,2900 
 Skin 1394,1  
3 Tumour  2899,4 1,7446 
 Skin 1661,9  
4 Tumour 3271,6 3,3662 
 Skin 971,9  
5 Tumour 2463,5 1,8399 
 Skin 1338,9  
6 Tumour 1972,3 1,5942 
 Skin 1237,2  
 
PET-images of the mice were also acquired, see Figure 5.3, and a comparison was 
made between the Cherenkov emission imaging and the PET-imaging. In addition the 
organs from two of the mice were taken out, Cherenkov emission images were taken 
and the activity was measured with a gamma counter, these measurements are 
further discussed in section 5.3. 
 
Figure 5. 3: PET-image of mouse number 1, with an uptake of 
89
Zr seen in the 
tumour and in the liver. 
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5.3 Ex vivo organ Cherenkov emission imaging 
In addition to the in vivo measurements, an ex vivo study of the animals was made. 
For this study two of the mice were dissected and Cherenkov emission images of the 
following organs were removed; heart, lungs, liver, spleen, kidneys, tumour, skin and 
muscle. This study was made partly because of the limited range of the Cherenkov 
light, in an ex vivo study it is possible to detect an uptake in organs located deeper 
inside the body. A photo of the extracted organs is seen in Figure 5.4 and a 
Cherenkov emission image of the same organs can be seen in Figure 5.5.  
 
 
Figure 5. 4: The organs taken from one of the dissected mice.  
 Top row from the left; heart, lungs, liver and spleen. 
 Bottom row from the left; kidneys, tumour, skin and 
muscle. 
 
 
Figure 5. 5: Cherenkov emission image of the organs seen in Figure 5.4. 
An uptake of zirconium is seen in the liver, the tumour and in the skin. 
In the ex vivo Cherenkov emission image an uptake of 89Zr is seen in the liver, this is 
not seen in the in vivo images due to the absorption when the emitted light travels 
through the body.  
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Regions of interest were drawn over the organs in the Cherenkov emission images, 
the radiance in these regions was measured and the liver to tumour ratio and the 
tumour to skin ratio was calculated. In Table 5.2 the mean radiance of the interesting 
organs and the calculated ratios can be seen. 
 
Table 5. 2: The mean radiance of the organs, the calculated liver to tumour ratio and the calculated 
tumour to skin ratio. 
Organs     
Mouse Organ Mean radiance 
[γ/cm²/sr/s] 
      
     
 
      
    
 
4 Tumour 2436 4,64  
 Liver 525   
1 Tumour 2144 2,2218  
 Liver 965   
     
    2 Tumour 2759  1,8689 
 Skin 1476   
      3 Tumour 822  0,9712 
 Skin 846   
 
To be able to make an attempt to quantify the Cherenkov emission images the 
activities of the organs were measured with a gamma counter; the measured 
activities are displayed in Table 5.3 below.  
 
Table 5. 3: The measured activities in the organs from mouse number one and mouse 
number four. 
Mouse 1  Mouse 4  
Organ Activity [kBq] Organ Activity [kBq] 
Heart 0,72 Heart 0,45 
Lungs 3,9 Lungs 2,14 
Liver 25,74 Liver 14,50 
Spleen 1,11 Spleen 0,86 
Kidneys 5,41 Kidneys 3,68 
Tumour 9,77 Tumour 15,61 
Skin 1,07 Skin 0,68 
Muscle 0,59 Muscle 0,1 
 
  
The measured activities were compared to the mean radiances from the Cherenkov 
emission images. Because of the difference in size between the tumour and the liver 
it is not a fair comparison to just look at the radiance and activity of the organs. Since 
the liver is almost six times as heavy as the tumour a direct comparison would be 
misleading, hence I choose to look at the radiances and activities per unit weight. In 
Table 5.4 one can see the measured radiance and activity, as well as the calculated 
radiance and activity per unit weight. 
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Table 5. 4: Results from the ex vivo experiments for mouse no. 1; the measured radiance and 
activity, and the calculated radiance and activity per unit weight. 
Organ Radiance 
[γ/cm²/sr/s] 
Radiance/weight 
[γ/cm²/sr/s/g] 
Activity 
[kBq] 
Activity/weight 
[kBq/g] 
Liver 965 569 26 15 
Tumour 2144 7393 10 34 
 
Since the liver also contains rather much blood the radiance seen is probably 
originating from the surface, due to the restricted range of the Cherenkov radiation 
in blood rich tissues. The high blood content could also explain the lower radiance 
per unit weight, since the blue wavelengths of the emitted Cherenkov light is heavily 
absorbed by it.  
6. Discussion 
The results shown in this thesis state that the relation between radiance and activity 
is linear with different inclination for different tissue types. These results confirm 
what has been shown by other groups and what is expected according to theory. A 
higher activity produces more detectable Cherenkov photons which gives a higher 
detected radiance, this renders Cherenkov emission imaging to potentially become 
an important imaging modality for longitudinal studies where the activity in an 
animal is monitored over a long time. 
From these results one can see that the amount of added bovine blood affects the 
radiance more than the amount of Intralipid, indicating that the radiance is more 
affected by the amount of absorbing material than by the amount of scattering 
material in the studied object.  One could from this draw the conclusion that the 
absorption of the light has a larger impact on the images than scattering. This fact 
has implications for organ imaging, which means that the Cherenkov radiance would 
need to be normalized against the blood content in each organ before making the 
relative comparison of the accumulation of a specific radionuclide in different organs. 
However, instrumentation for assessment of blood concentration is readily available 
through fiber optic broadband optical spectroscopy which means this is not a 
problem [20].  
The theoretical 1/λ2 dependence is also verified by the shown results. Even if these 
results are promising, they are not statistically significant due to the fact that only 
one series of measurements was made in this study and we did not have the 
possibility to study all wavelengths of the emitted Cherenkov light.  
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The results from the comparison between different nuclides show that a nuclide with 
a higher energy gives more detectable light, which is rather obvious if you look at the 
table showing the number of emitted Cherenkov photons produced by beta particles 
of different energies [10]. Unfortunately there was no possibility to make an 
extensive investigation on the nuclide dependence of the radiance, but the results 
obtained are in good agreement with the theoretical expectations. It would have 
been interesting to make more experiments to obtain a larger set of data to draw 
conclusions from.   
In this study there were no quantitative measurements made to determine the 
difference in spatial resolution for the two nuclides, instead a brief qualitative 
comparison of the images was made. The images obtained from the energy 
dependence measurements indicate that the spatial resolution is somewhat better 
for the nuclide with higher energy at small depths, since the image of the test tube 
looks wider for the nuclide with lower energy. For deeper positioning of the test tube 
there is no larger difference between the nuclides, possibly the resolution looks 
better for the nuclide with the lower energy.  
The measurements made to investigate the relation between radiance and activity 
show that for all different concentrations of Intralipid and bovine blood the radiance 
is linearly dependent of the activity.  This means that if the absorbing and scattering 
properties of the studied medium are fairly constant one can accomplish longitudinal 
studies with very good results. Reasonably the same kinetics curve for the tumour 
should be obtained with CLI as well as PET, SPECT or gamma counters. 
7. Conclusions 
Cherenkov emission imaging can be used for radionuclide localization in pre-clinical 
animal studies, this means that a possible application for the imaging method is to 
study selective uptake in (superficial) tumours over time. Another possible 
application for Cherenkov emission imaging could be to compare the efficiency of 
different monoclonal antibodies or other types of tracers in small animals.   
To be able to really make quantitative measurements you need to know, or at least 
be able to estimate, the amount of blood in the observed organs and make 
corrections for this. Fortunately, there are a number of optical methods to measure 
blood concentrations that can help us get around this problem.  
As with all new methods and approaches, the CLI method needs to be investigated 
further before being implemented in preclinical or clinical use. At the moment the 
method seems to be able to provide a low-cost high-throughput alternative to 
preclinical PET, at least for superficial tumours in mice and for ex vivo measurements. 
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